On December 14, the signing ceremony of 2023 Hangzhou Medical Health International Innovation and Entrepreneurship Competition was successfully held in the High-tech Zone (Binjiang). The competition is co-sponsored by Tailong Investment, Hangzhou Capital, Gaoxin Capital Investment and Taiyu Investment. Wang Lisheng, deputy director of Hangzhou High-tech Zone (Binjiang) Management Committee, was invited to attend the event.

The 2023 Medical International Innovation and Entrepreneurship Competition aims to explore early projects such as biomedicine, innovative medical devices, CXO core services and digital medicine, incubate and cultivate a number of "specialized and innovative" excellent medical enterprises, lead the transformation of life science innovation achievements, and break through key "bottleneck" technologies. Further promote the innovation and development of Hangzhou's medical and health high-end industries, improve the industrial ecosystem, and build a trillion-level industrial cluster.

The competition was officially launched on April 17, lasting 9 months, and selected 5 innovative drug projects and 3 innovative medical device projects from more than 200 projects, of which 6 projects are intended to settle or have settled in the high-tech Zone (Binjiang). Tai Kun Fund intends to invest in the above 8 winning projects, with an investment amount of more than 180 million yuan. At the scene, the winning award and signing ceremony of 2023 Hangzhou Medical Health International Innovation and Entrepreneurship Competition were held.